98 related articles for article (PubMed ID: 3092786)
1. [Pathomorphosis of bladder cancer after endolymphatic polychemotherapy].
Danil'chenko SA; Shlopov VG; Serniak PS; Geev IuV
Arkh Patol; 1986; 48(7):31-5. PubMed ID: 3092786
[TBL] [Abstract][Full Text] [Related]
2. [Intra-arterial chemotherapy of patients in the late stages of bladder cancer].
Dunchik VN; Drozdovskiĭ BIa; Kariakin OB; Grishin GN
Urol Nefrol (Mosk); 1985; (2):19-23. PubMed ID: 3992752
[No Abstract] [Full Text] [Related]
3. [Retrospective evaluation of the efficacy of regional endolymphatic polychemotherapy in kidney cancer depending on the histologic structure of the tumor].
Serniak PS; Shlopov VG; Vlodavskiĭ EA; Geev IuV
Urol Nefrol (Mosk); 1989; (3):40-2. PubMed ID: 2505424
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
Sulkes A; Fuks Z
Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
[No Abstract] [Full Text] [Related]
7. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
[TBL] [Abstract][Full Text] [Related]
8. Current topics in the pathology of bladder cancer.
Murphy WM
Pathol Annu; 1983; 18 Pt 1():1-25. PubMed ID: 6410347
[No Abstract] [Full Text] [Related]
9. Chemotherapy of metastatic bladder cancer.
Yagoda A
Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
[No Abstract] [Full Text] [Related]
10. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
Pollera CF; Nelli F
Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
[TBL] [Abstract][Full Text] [Related]
11. [Reactions of tumorous urinary bladders following local and systemic therapy with cytostatic drugs].
Theuring F; Ecke M; Lenz E; Langen L
Z Urol Nephrol; 1988 Apr; 81(4):219-25. PubMed ID: 3400350
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy and chemotherapy in infiltrating bladder tumors].
Durdux C; Housset M
Rev Prat; 1997 Feb; 47(4):392-5. PubMed ID: 9114525
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
15. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
[No Abstract] [Full Text] [Related]
16. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant chemotherapy of invasive bladder cancer].
Rassweiler J
Urologe A; 1994 Nov; 33(6):576-81. PubMed ID: 7817459
[TBL] [Abstract][Full Text] [Related]
18. [Concurrent radio-chemotherapy in infiltrating cancer of the bladder: a new therapeutic approach?].
Housset M; Dufour B; Durdux C; Chrétien Y; Méjean A; Baillet F
Cancer Radiother; 1998 Apr; 2 Suppl 1():67s-72s. PubMed ID: 9749082
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study.
Gagliano RG; Stephens RL; Costanzi JJ; Oishi N; Stuckey WJ; Grozea PN; Frank J; Crawford ED
Cancer Treat Rep; 1984; 68(7-8):1025-6. PubMed ID: 6430559
[No Abstract] [Full Text] [Related]
20. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
Guazzieri S; Sperandio P; Fandella A; Garbeglio A; Pegoraro V; Chiarion V; Fiorentino M; Pagano F
Prog Clin Biol Res; 1988; 260():599-602. PubMed ID: 3362909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
